MAOA and depressive disorder: A significant increase in the monoamine oxidase MAO-A is found in association with the pathogenesis of major depressive disorders [95], and selective serotonin reuptake inhibitor treatment elevated MAO-A binding in the brain regions of patients with depression, which contributes to recurrence [96].